BioNTech SE (BNTX) Revenue Growth (3y) (2021 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 122.97% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.94% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 4.47% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 54.05% |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | -37.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -37.68% |
| Sep 30, 2025 | -20.17% |
| Jun 30, 2025 | -55.77% |
| Mar 31, 2025 | -84.95% |
| Dec 31, 2024 | -91.77% |
| Sep 30, 2024 | -42.47% |
| Jun 30, 2024 | -82.32% |
| Mar 31, 2024 | -84.07% |
| Dec 31, 2023 | -98.43% |
| Sep 30, 2023 | 131.22% |
| Jun 30, 2023 | 58.34% |
| Mar 31, 2023 | 255.22% |
| Sep 30, 2022 | 378.30% |
| Jun 30, 2022 | 390.11% |
| Mar 31, 2022 | 522.02% |
| Dec 31, 2021 | 343.00% |
| Sep 30, 2021 | 571.35% |